Elżbieta Kojro

4.9k citations
44 papers · 3.9k indexed · 2 hit papers · h-index 25

Elżbieta Kojro

44 papers receiving 3.9k citations

Hit Papers

Low cholesterol stimulates the nonamyloidogenic pathway b...6761999202620082017250500750

Peers

Elżbieta Kojro
Comparison fields: 5 of 109
  • Physiology 1.9k
  • Clinical Biochemistry 330
  • Immunology and Allergy 261
  • Cellular and Molecular Neuroscience 732
  • Pharmacology 552
Replace Robert J. Mark with:
Robert J. Mark United States
George R. Jackson United States
Marc Gleichmann United States
Ward A. Pedersen United States
David E. Kang United States
Suzana Petanceska United States
Ana Pérez‐Castillo Spain
Daniel Paris United States
Hagit Eldar-Finkelman Israel
Harry M. Lander United States
Elżbieta Kojro relative to Robert J. Mark United States Robert J. Mark's profile →
Citations per field
00.5×6.1×
Robert J. Mark · 1×
Citations per year

Countries citing papers authored by Elżbieta Kojro

Since Specialization
Citations

This map shows the geographic impact of Elżbieta Kojro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elżbieta Kojro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elżbieta Kojro more than expected).

Fields of papers citing papers by Elżbieta Kojro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elżbieta Kojro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elżbieta Kojro. The network helps show where Elżbieta Kojro may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elżbieta Kojro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elżbieta Kojro Line = papers co-authored together Elżbieta Kojro links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20116
2 201038
3 200940
4 2008239
5 2006156
6 2004499
7 2003107
8 200060
9 19986
10 199810
11 1996112
12 199523
13 199366
14 199287
15 199142
16 199039
17 19907
18 19898
19 19875
20 19873

About Elżbieta Kojro

Elżbieta Kojro is a scholar working on Endocrine and Autonomic Systems, Social Psychology and Clinical Biochemistry, having authored 44 papers that have together received 3.9k indexed citations. Recurring topics across this work include Neuroendocrine regulation and behavior (12 papers), Alzheimer's disease research and treatments (10 papers), Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (9 papers), Signaling Pathways in Disease (4 papers), Advanced Glycation End Products research (4 papers), Ion Transport and Channel Regulation (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Physiology (1.9k citations), Clinical Biochemistry (330 citations) and Immunology and Allergy (261 citations). Elżbieta Kojro has collaborated with scholars based in Germany, Poland and Belgium. Frequent co-authors include Falk Fahrenholz, Rolf Postina, Sven Lammich, Gerald Gimpl, Sandra L. Gilbert, Winfried März, Marek Jasionowski, Roland Pfeiffer, Christian Haass and Kristina Endres.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026